Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
Anna Lahti(Tampere University), Katriina Aalto‐Setälä(Tampere University), Olli Silvennoinen(University of Helsinki), Hugh Chapman(Orion Corporation (Finland)), Ville Kujala(Harvard University), Erja Kerkelä(Finnish Red Cross), Jari Hyttinen(Tampere University), Bruce R. Conklin(Gladstone Institutes), Ari Koivisto(Orion Corporation (Finland)), Kimmo Kontula(University of Helsinki), Heikki Swan(University of Helsinki), Shinya Yamanaka(Kyoto University), Mari Pekkanen-Mattila(King's College London)
Cited by 291
Related Papers
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
|Cell|1992|2.3k
Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia
|Circulation|2001|734
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
|Scientific Reports|2014|691
Advances in TRP channel drug discovery: from target validation to clinical studies
|Nature Reviews Drug Discovery|2021|519